Coverage
-
November 12, 2013
Pfizer Inc. has reached a settlement with thousands of independent pharmacies to exit litigation alleging it colluded with other drugmakers to charge the retailers higher prices than other preferred customers, leaving them at an unfair disadvantage, according to a motion filed in New York federal court Friday.
1 other articles on this case.
View all »